Q3 2024 · 13F-HR
Venrock Adviser, LLCholdings as filed
Filed 2024-11-14 · accession 0001104659-24-118950
$1.91B
Reported value
38
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $498.9M | 26.1% | 8,493,321 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $111.0M | 5.82% | 12,762,462 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $102.8M | 5.39% | 4,026,331 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $88.3M | 4.63% | 3,882,709 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $83.5M | 4.37% | 9,825,000 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $79.0M | 4.14% | 2,685,448 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $78.1M | 4.09% | 2,173,913 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $75.6M | 3.96% | 3,085,620 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $72.4M | 3.79% | 6,249,731 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $62.9M | 3.29% | 3,395,606 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $61.4M | 3.22% | 5,684,167 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $47.8M | 2.50% | 1,744,373 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $47.6M | 2.49% | 4,400,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $45.4M | 2.38% | 907,963 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $45.0M | 2.36% | 4,394,527 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $44.3M | 2.32% | 16,216,216 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $40.6M | 2.13% | 706,131 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $38.1M | 1.99% | 3,458,645 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $28.4M | 1.49% | 3,410,058 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $27.7M | 1.45% | 5,555,555 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $26.7M | 1.40% | 1,000,000 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $24.9M | 1.30% | 1,609,569 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $23.5M | 1.23% | 3,565,841 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $23.1M | 1.21% | 1,379,965 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $21.4M | 1.12% | 11,328,000 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $18.1M | 0.95% | 9,000,000 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $15.5M | 0.81% | 1,345,780 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $11.4M | 0.60% | 3,422,656 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $11.2M | 0.59% | 454,450 | Common | SOLE |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $10.3M | 0.54% | 1,467,048 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $9.2M | 0.48% | 5,389,259 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $8.2M | 0.43% | 2,023,166 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $7.5M | 0.39% | 750,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $7.4M | 0.39% | 1,563,952 | Common | SOLE |
| G1933S101 | CASIF | CASI PHARMACEUTICALS INC | $6.1M | 0.32% | 987,259 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $3.0M | 0.16% | 1,555,556 | Common | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $2.2M | 0.12% | 33,177 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $720,832 | 0.04% | 208,333 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.